RecruitingNCT05908682

Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes

A Single-arm Safety Study of Subjects Exposed to Ibrexafungerp Whilst Pregnant, Including Infant Outcomes Up to One Year

Sponsor

Scynexis, Inc.

Enrollment

100 participants

Start Date

Jul 28, 2022

Study Type

OBSERVATIONAL

Conditions

Vulvovaginal candidiasis Vaginal Candidiasis Candida Infection

Summary

This is an ongoing evaluation of subjects exposed to ibrexafungerp while pregnant. The study population will include pregnant women of any age.

Eligibility

Sex: FEMALEMin Age: 0 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Non-interventional study for people with candida infection, vaginal candidiasis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 0 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.